v3.26.3
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenue:        
Total revenue $ 0 $ 334 $ 235 $ 1,955
Operating expenses:        
Research and development 6,199 5,452 22,441 17,735
Selling, general and administrative 3,562 3,287 12,268 10,815
Total operating expenses 9,761 8,739 34,709 28,550
Loss from operations (9,761) (8,405) (34,474) (26,595)
Other (income) expense:        
Amortization of debt issuance costs and discount 0 0 0 312
Interest income (617) (454) (1,786) (1,759)
Interest expense 0 0 0 173
Other income (870) 0 (1,609) 0
Warrant liabilities fair value adjustment 184 640 (8,719) (4,454)
Total other (income) expense (1,303) 186 (12,114) (5,728)
Net loss $ (8,458) $ (8,591) $ (22,360) $ (20,867)
Net loss per share - basic $ (0.71) $ (1.38) $ (2.23) $ (3.36)
Net loss per share - diluted $ (0.71) $ (1.38) $ (2.23) $ (3.36)
Weighted average common shares outstanding - basic 11,842,836 6,237,361 10,037,699 6,212,127
Weighted average common shares outstanding - Diluted 11,842,836 6,237,361 10,037,699 6,212,127
License Agreement Revenue        
Revenue:        
Total revenue $ 0 $ 334 $ 235 $ 1,955